全文获取类型
收费全文 | 63643篇 |
免费 | 6724篇 |
国内免费 | 2376篇 |
专业分类
耳鼻咽喉 | 147篇 |
儿科学 | 639篇 |
妇产科学 | 253篇 |
基础医学 | 2700篇 |
口腔科学 | 426篇 |
临床医学 | 5566篇 |
内科学 | 7490篇 |
皮肤病学 | 1073篇 |
神经病学 | 2207篇 |
特种医学 | 637篇 |
外国民族医学 | 7篇 |
外科学 | 2069篇 |
综合类 | 8338篇 |
现状与发展 | 6篇 |
一般理论 | 3篇 |
预防医学 | 3971篇 |
眼科学 | 650篇 |
药学 | 29630篇 |
26篇 | |
中国医学 | 3025篇 |
肿瘤学 | 3880篇 |
出版年
2024年 | 180篇 |
2023年 | 1008篇 |
2022年 | 1532篇 |
2021年 | 2271篇 |
2020年 | 2317篇 |
2019年 | 2352篇 |
2018年 | 2406篇 |
2017年 | 2691篇 |
2016年 | 2539篇 |
2015年 | 2548篇 |
2014年 | 4295篇 |
2013年 | 7054篇 |
2012年 | 4354篇 |
2011年 | 4391篇 |
2010年 | 3531篇 |
2009年 | 3114篇 |
2008年 | 2910篇 |
2007年 | 2934篇 |
2006年 | 2645篇 |
2005年 | 2364篇 |
2004年 | 2021篇 |
2003年 | 1842篇 |
2002年 | 1421篇 |
2001年 | 1364篇 |
2000年 | 1040篇 |
1999年 | 892篇 |
1998年 | 779篇 |
1997年 | 736篇 |
1996年 | 603篇 |
1995年 | 558篇 |
1994年 | 481篇 |
1993年 | 404篇 |
1992年 | 462篇 |
1991年 | 385篇 |
1990年 | 311篇 |
1989年 | 250篇 |
1988年 | 247篇 |
1987年 | 240篇 |
1986年 | 185篇 |
1985年 | 202篇 |
1984年 | 165篇 |
1983年 | 124篇 |
1982年 | 109篇 |
1981年 | 91篇 |
1980年 | 57篇 |
1979年 | 57篇 |
1978年 | 69篇 |
1977年 | 48篇 |
1976年 | 49篇 |
1975年 | 50篇 |
排序方式: 共有10000条查询结果,搜索用时 390 毫秒
61.
目的:探讨骨伤科中成药的用药规律,为临床合理用药及新药开发提供参考。方法:以《中国药典》2015年版一部收载的骨伤科类中成药共149个为研究对象,运用频数分析的方法研究其主治病症、所用剂型、各类方剂高频药物、核心药物组成,分析骨伤科中成药用药规律。结果:常用骨伤科中成药中治疗骨关节痹症的最多,其次为跌打损伤和骨关节退行性疾病的中成药;剂型以胶囊剂、片剂、丸剂为主;以活血化瘀药、祛风湿药、补虚药为核心药物组合,各类方剂中三者比例偏重不同。结论:通过对研究结果进行分析,提出了新药研发的方向。 相似文献
62.
Stephen Hanessian 《ACS medicinal chemistry letters》2016,7(1):6-9
Current major advances in drug discovery
can be traced back to
pioneering contributions originating from academics over a century
ago. Living in a symbiotic yet noninvasive coexistence, the academic
community and the pharmaceutical industry have strived, each in their
own way, to develop the modern medicines that benefit humankind today.
The subject is presented from a historical and personal perspective. 相似文献
63.
目的探讨益气化瘀解毒方干预后对Sorafenib获得性耐药人肝癌QGY7702细胞(QGY7702/Sora)增殖及MRP、GST-π和Topo Ⅱ基因表达的影响。方法培养QGY7702/Sora细胞和QGY7702细胞,利用Cell Counting Kit-8(CCK-8)法检测Sorafenib对细胞的半数抑制率浓度(IC50值),计算耐药指数RI;观察益气化瘀解毒方对耐药细胞的增殖影响;采用荧光定量PCR检测药物干预前后2种细胞中MRP、GST-π和Topo Ⅱ基因表达水平。结果亲本细胞和耐药细胞Sorafenib的IC50值分别为(7.993±0.522)μmol/L和(19.651±1.216)μmol/L,RI约为2.5。益气化瘀解毒方可抑制耐药细胞的增殖活性。2种细胞的MRP、GST-π、Topo Ⅱ表达量无明显差异(P>0.05)。Sorafenib组可促进耐药细胞MRP 、GST-π基因的过表达(P<0.05),益气化瘀解毒方组可抑制GST-π基因的过表达(P<0.01),且联合Sorafenib可显著提高Topo Ⅱ基因的表达量(P<0.01)。结论 QGY7702/Sora细胞MRP、GST-π和Topo Ⅱ的表达水平与亲本细胞无显著差异。耐药细胞对Sorafenib敏感性降低与MRP、GST-π过表达相关,而益气化瘀解毒方拮抗Sorafenib耐药与抑制GST-π过表达相关。 相似文献
64.
65.
Theodore C. Bania MD MS Tom Ashar MD Gregory Press MD Patricia M. Carey MD 《Academic emergency medicine》2003,10(7):697-704
Long-term daily use of gamma-hydroxybutyrate (GHB) and related compounds has recently been associated with a withdrawal syndrome. To the best of the authors' knowledge, there are currently no animal models of GHB withdrawal. OBJECTIVES: The authors studied and described the effect of chronic dosing of GHB (3-6 days) on tolerance and withdrawal in a rat model. METHODS: Rats were administered GHB every three hours via intraperitoneal catheter. Groups of rats (2 per group) were dosed with GHB for either 3 (24 doses), 4 (32 doses), 5 (40 doses), or 6 (48 doses) days. The GHB dose was 0.25 g/kg for doses 1-8, 0.75 g/kg for doses 9-12, 1 g/kg for doses 13-16, 1.25 g/kg for doses 17-24, 1.5 g/kg for doses 25-32, 1.75 g/kg for doses 33-40, and 2 g/kg for doses 41-48. Following the last dose of GHB, the rats were scored using a 16-point ethanol intoxication-withdrawal scale rating spontaneous behaviors, response to handling, grooming, and neurological signs. Lower scores indicate intoxication, while higher scores indicate withdrawal. Scores were recorded at hours 0, 1, 2, 3, 4, 5, 6, 9, 12, and 24. RESULTS: Tolerance: Rats dosed with GHB for more days were less intoxicated one hour after their last GHB dose despite receiving higher doses. WITHDRAWAL: The scores for all rats dosed with GHB increased at hours 4 (p = 0.028), 5 (p = 0.037), 6 (p = 0.007), and 9 (p = 0.024) after the last dose, indicating withdrawal. The scores demonstrated a linear increase dependent upon the number of days of GHB dosing at hours 3 (p < 0.000), 4 (p = 0.004), 5 (p = 0.002), and 12 (p = 0.039) as well as prior to the last dose at hour 0 (p = 0.000). No rats developed seizures. CONCLUSIONS: Tolerance and mild withdrawal in rats can be induced by administering intraperitoneal GHB every three hours for 3-6 days. More prolonged dosing and higher doses of GHB may be necessary to induce severe withdrawal. 相似文献
66.
67.
68.
AKIKO TANAKA MASAHIRO MATSUMOTO YUJIRO HAYASHI KOJI TAKEUCHI 《Journal of gastroenterology and hepatology》2006,20(1):38-45
Background and Aim: We recently reported that cyclooxygenase (COX)-2 is upregulated in the rat small intestine after administration of indomethacin, and this may be the key to non-steroidal anti-inflammatory drug (NSAID)-induced intestinal damage. The present study investigated the mechanism for COX-2 expression induced in the rat small intestine by indomethacin, in relation with ulcerogenic processes.
Methods: Animals were given indomethacin or SC-560 p.o., and the intestinal mucosa was examined 24 h later.
Results: Indomethacin caused hemorrhagic lesions in the small intestine, accompanied with an increase in intestinal motility, bacterial invasion and inducible nitric oxide synthase (iNOS) activity, as well as the expression of COX-2 mRNA in the mucosa. Although SC-560 did not cause any damage, this agent caused intestinal hypermotility, the bacterial invasion and the upregulation of COX-2 expression. The mucosal PGE2 content was decreased by SC-560 at 3 h but recovered 12 h later, and this recovery of PGE2 was attenuated by both atropine and ampicillin, in addition to rofecoxib. The intestinal hypermotility response to indomethacin was prevented by both 16,16-dimethyl PGE2 and atropine, but not ampicillin. Yet all these agents inhibited not only the bacterial invasion but also the expression of COX-2 and iNOS activity in the intestinal mucosa following indomethacin treatment, resulting in the prevention of intestinal lesions.
Conclusion: These results suggest that COX-2 expression in the intestinal mucosa following the administration of indomethacin is associated with intestinal hypermotility and bacterial invasion. The intestinal hypermotility caused by COX-1 inhibition may be a key to COX-2 expression after administration of NSAIDs and their intestinal ulcerogenic properties. 相似文献
Methods: Animals were given indomethacin or SC-560 p.o., and the intestinal mucosa was examined 24 h later.
Results: Indomethacin caused hemorrhagic lesions in the small intestine, accompanied with an increase in intestinal motility, bacterial invasion and inducible nitric oxide synthase (iNOS) activity, as well as the expression of COX-2 mRNA in the mucosa. Although SC-560 did not cause any damage, this agent caused intestinal hypermotility, the bacterial invasion and the upregulation of COX-2 expression. The mucosal PGE
Conclusion: These results suggest that COX-2 expression in the intestinal mucosa following the administration of indomethacin is associated with intestinal hypermotility and bacterial invasion. The intestinal hypermotility caused by COX-1 inhibition may be a key to COX-2 expression after administration of NSAIDs and their intestinal ulcerogenic properties. 相似文献
69.
Michael W. Anderson MD Kanika Sharma MD Colin M. Feeney MD 《Academic emergency medicine》1997,4(8):805-809
The incidence of wound botulism is increasing and the epidemiology of the disease is changing. The majority of new cases are associated with injection drug use, in particular, the use of Mexican black tar heroin. This case report and discussion of wound botulism illustrate the following important points: Dysphagia, dysphonia, diplopia, and descending paralysis, in association with injection drug use, should alert the treating physician to the possibility of wound botulism. In such patients, the onset of respiratory failure may be sudden and without clinically obvious signs of respiratory weakness. For the reported patient, maximum inspiratory force measurements were the only reliable indicator of respiratory muscle weakness. This is a measurement not routinely performed in the ED, but may prove essential for patients with suspected wound botulism. To minimize the effect of the botulinum toxin and to decrease length of hospital stay, antitoxin administration and surgical wound debridement should be performed early. 相似文献
70.
药物传递系统(DDS)Ⅳ腔道给药传递系统 总被引:2,自引:0,他引:2
腔道给药是能起全身作用、避开肝首过代谢作用、患者便于自用的非损伤性给药途径。本文着重介绍影响鼻腔、阴道给药药物吸收的生物因素和剂型因素及正在开发的腔道给药传递系统。 相似文献